A practical method of estimating medium-heterogeneity corrected dose without a Monte Carlo calculation in ocular brachytherapy using 125I COMS plaques

Yongsook C Lee; Mehran Nik Akhtar; Yongbok Kim; Jae Won Jung

doi:10.1016/j.brachy.2024.01.001

A practical method of estimating medium-heterogeneity corrected dose without a Monte Carlo calculation in ocular brachytherapy using ¹²⁵I COMS plaques

Brachytherapy. 2024 Feb 8:S1538-4721(24)00005-9. doi: 10.1016/j.brachy.2024.01.001. Online ahead of print.

Authors

Yongsook C Lee¹, Mehran Nik Akhtar², Yongbok Kim³, Jae Won Jung⁴

Affiliations

¹ Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL; Department of Radiation Oncology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL.
² Department of Physics, East Carolina University, Greenville, NC.
³ Department of Radiation Oncology, Duke University, Durham, NC. Electronic address: yongbok.kim@duke.edu.
⁴ Department of Radiation Oncology, East Carolina University, Greenville, NC.

PMID: 38336557
DOI: 10.1016/j.brachy.2024.01.001

Abstract

Purpose: To provide a practical method of estimating medium-heterogeneity corrected dose without a Monte Carlo (MC) calculation in ocular brachytherapy using ¹²⁵I Collaborative Ocular Melanoma Study (COMS) plaques.

Methods and materials: Using egs_brachy, MC simulations (1) under task group-43 assumptions with fully loaded seed configurations in water (HOMO) and (2) with effects of plaque backing, insert and inter-seed interactions (HETERO) were performed for seven ¹²⁵I COMS plaques (10 mm-22 mm in diameter), and homogeneous dose (D_HOMO) and heterogeneous dose (D_HETERO) for central-axis and off-axis points were determined. For D_HOMO, 85 Gy was normalized to a depth of 5 mm. Central-axis heterogeneity correction factors (HCFs) from a depth of 0 mm (inner sclera) to 22 mm (opposite retina) were derived from a ratio of D_HETERO to D_HOMO. Off-axis HCFs for optic disc/macula and lens as a function of distance from optic disc/macula (DT/MT) for various basal dimensions of tumor (BD/BM) were derived from D_HETERO/D_HOMO.

Results: Central-axis HCF varied with a dose reduction of 10.3-19.8% by heterogeneity. Off-axis HCF for optic disc/macula varied significantly depending on DT/MT and BD/BM with a dose reduction of 11.3-38.3%. Off-axis HCF for lens had a dependence on MT and BM with its variation of 11.0-19.0%. A clinical example of using HCFs to estimate D_HETERO was presented.

Conclusions: The practical method of using depth-dependent central-axis HCF and DT/MT- and BD/BM-dependent off-axis HCF provided in this study will facilitate a heterogeneous dose estimate for ¹²⁵I COMS plaques without MC calculations.

Keywords: Collaborative ocular melanoma study; Egs_brachy; Heterogeneity correction factors; Heterogeneous dose; Monte Carlo; Ocular brachytherapy.